Orchestra Biomed Holdings Inc
OBIO2.685USD
+0.245+10.04%
交易中 （美東）報價延遲15分鐘
102.87M總市值
虧損本益比TTM
關於 Orchestra Biomed Holdings Inc 公司
Orchestra BioMed Holdings, Inc. 是一家生物醫學創新公司。其主要候選產品是 BackBeat 心臟神經調節療法 (BackBeat CNT)，用於治療高血壓 (HTN)，高血壓是全球最大的死亡風險因素。該公司還在開發 Virtue Sirolimus 血管輸注球囊 (Virtue SAB)，用於治療動脈粥樣硬化性動脈疾病，動脈粥樣硬化性動脈疾病是全球最大的死亡原因。該公司正在開發基於專利 CNT 技術的生物電子療法。BackBeat CNT，也稱爲房室間隔調節 (AVIM) 療法，是一種生物電子療法候選產品，旨在大幅持續降低血壓。Virtue SAB 是一種專有的藥物/設備組合候選產品，用於治療動脈疾病，旨在在球囊血管成形術期間向血管壁輸送專有的、研究性的、緩釋的雷帕黴素 (SirolimusEFR) 製劑，無需球囊塗層或永久植入。
公司簡介
公司代碼OBIO
公司名稱Orchestra Biomed Holdings Inc
上市日期Aug 04, 2020
CEOMr. David P. Hochman
員工數量70
證券類型Ordinary Share
年結日Aug 04
公司地址150 Union Square Drive
城市NEW HOPE
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編18938
電話16463439298
網址
公司代碼OBIO
上市日期Aug 04, 2020
CEOMr. David P. Hochman
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. David P. Hochman
Mr. David P. Hochman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
410.20K
-7.66%
Mr. Andrew Lawrence Taylor
Mr. Andrew Lawrence Taylor
Chief Financial Officer
Chief Financial Officer
98.07K
-22.32%
Dr. Eric S. Fain, M.D.
Dr. Eric S. Fain, M.D.
Lead Independent Director
Lead Independent Director
46.81K
+57.25%
Ms. Pamela Ann Connealy
Ms. Pamela Ann Connealy
Independent Director
Independent Director
33.71K
+58.35%
Mr. David Pacitti
Mr. David Pacitti
Independent Director
Independent Director
22.46K
+123.70%
Mr. John Mack
Mr. John Mack
Independent Director
Independent Director
18.43K
+206.93%
Mr. Darren R. Sherman
Mr. Darren R. Sherman
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
--
--
Mr. Christopher (Chris) Cleary
Mr. Christopher (Chris) Cleary
Independent Director
Independent Director
--
--
Mr. Jason Aryeh
Mr. Jason Aryeh
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. David P. Hochman
Mr. David P. Hochman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
410.20K
-7.66%
Mr. Andrew Lawrence Taylor
Mr. Andrew Lawrence Taylor
Chief Financial Officer
Chief Financial Officer
98.07K
-22.32%
Dr. Eric S. Fain, M.D.
Dr. Eric S. Fain, M.D.
Lead Independent Director
Lead Independent Director
46.81K
+57.25%
Ms. Pamela Ann Connealy
Ms. Pamela Ann Connealy
Independent Director
Independent Director
33.71K
+58.35%
Mr. David Pacitti
Mr. David Pacitti
Independent Director
Independent Director
22.46K
+123.70%
Mr. John Mack
Mr. John Mack
Independent Director
Independent Director
18.43K
+206.93%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
RTW Investments L.P.
21.68%
Medtronic PLC
15.32%
Perceptive Advisors LLC
11.99%
The Vanguard Group, Inc.
3.41%
BlackRock Institutional Trust Company, N.A.
3.41%
Other
44.19%
持股股東
持股股東
佔比
RTW Investments L.P.
21.68%
Medtronic PLC
15.32%
Perceptive Advisors LLC
11.99%
The Vanguard Group, Inc.
3.41%
BlackRock Institutional Trust Company, N.A.
3.41%
Other
44.19%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
27.20%
Corporation
17.81%
Private Equity
11.99%
Investment Advisor
9.79%
Individual Investor
4.00%
Research Firm
0.27%
Family Office
0.22%
Bank and Trust
0.07%
Hedge Fund
0.06%
Other
28.60%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
130
27.28M
71.20%
-3.94M
2025Q1
136
28.97M
75.74%
-4.21M
2024Q4
145
29.39M
77.32%
-6.48M
2024Q3
139
29.24M
78.21%
-5.77M
2024Q2
173
27.85M
75.29%
-10.18M
2024Q1
173
26.52M
74.14%
-11.97M
2023Q4
170
26.50M
74.14%
-13.80M
2023Q3
165
26.04M
76.97%
-3.70M
2023Q2
163
22.38M
66.83%
-7.49M
2023Q1
132
21.37M
67.60%
-7.36M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
RTW Investments L.P.
8.31M
21.68%
+99.90K
+1.22%
Apr 30, 2025
Medtronic PLC
5.87M
15.32%
--
--
Apr 28, 2025
Perceptive Advisors LLC
4.59M
11.99%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
1.31M
3.41%
-9.80K
-0.74%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.31M
3.41%
-21.41K
-1.61%
Mar 31, 2025
HSAC 2 Holdings LLC
955.71K
2.49%
-3.41M
-78.08%
Aug 05, 2024
Geode Capital Management, L.L.C.
595.43K
1.55%
+22.99K
+4.02%
Mar 31, 2025
BlackRock Financial Management, Inc.
560.10K
1.46%
-11.41K
-2.00%
Mar 31, 2025
State Street Global Advisors (US)
473.72K
1.24%
+26.01K
+5.81%
Mar 31, 2025
T. Rowe Price Associates, Inc.
440.84K
1.15%
-27.66K
-5.90%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
Schwab U.S. Broad Market ETF
0%
Global X Russell 2000 ETF
0%
SPDR SSGA US Small Cap Low Volatility Index ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Morningstar Small-Cap ETF
0%
iShares Russell 2000 Growth ETF
0%
Schwab U.S. Small-Cap ETF
0%
查看更多
iShares Micro-Cap ETF
佔比0.01%
Schwab U.S. Broad Market ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
SPDR SSGA US Small Cap Low Volatility Index ETF
佔比0%
Global X Russell 2000 Covered Call ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
ProShares UltraPro Russell2000
佔比0%
iShares Morningstar Small-Cap ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
Schwab U.S. Small-Cap ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
